Date: 2011-09-28
Type of information: Fundraising
Company: ProteoNic (The Netherlands)
Investors: Fairbanks Investment Fund (USA) - existing shareholders
Amount: €6 million
Funding type: fundraising
Planned used: The funding will be used to accelerate commercialization of ProteoNic’s proprietary UNic™ recombinant protein yield enhancement technology and expand the company’s capabilities in the area of cell line generation and contract services.
Others: ProteoNic has successfully completed a € 6 mln equity financing round led by US-based Fairbanks Investment Fund (FIF), with existing shareholders participating.
Therapeutic area: Technology - Services
